Managing persistent neuropathic pain in the elderly

Geriatrics

Volumn 60, Issue 11 SUPPL., 2005, Pages 9-14

  McCarberg, Bill H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; BENZYDAMINE; BIPERIDEN; CAPSAICIN; CARBAMAZEPINE; CHLORPROTHIXENE; DESIPRAMINE; DEXTROMETHORPHAN; GABAPENTIN; GANODERMA LUCIDUM EXTRACT; INDOMETACIN; KETAMINE; LIDOCAINE; LORAZEPAM; METHYLPREDNISOLONE; MORPHINE SULFATE; NICARDIPINE; NORTRIPTYLINE; OPIATE AGONIST; OXYCODONE; PIROXICAM; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRIAMCINOLONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINCRISTINE; ZIMELDINE; NARCOTIC ANALGESIC AGENT;

ANTICHOLINERGIC EFFECT; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; CRYOTHERAPY; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG SENSITIVITY; ELDERLY CARE; HEARING IMPAIRMENT; HELIUM NEON LASER; HERPES ZOSTER; HUMAN; IONTOPHORESIS; LOW BACK PAIN; MUSCULOSKELETAL DISEASE; NAUSEA; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; OSTEOARTHRITIS; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; STELLATE GANGLION BLOCK; TACHYCARDIA; TRIGEMINUS NEURALGIA; UNITED STATES; URINE RETENTION; VISUAL IMPAIRMENT; XEROSTOMIA; AGED; AGING; ARTICLE; CHRONIC DISEASE; CLASSIFICATION; COMORBIDITY; CONTROLLED CLINICAL TRIAL; GERIATRICS; METABOLISM; NEUROLOGIC DISEASE; PAIN; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

AGED; AGING; ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHRONIC DISEASE; COMORBIDITY; GERIATRICS; HUMANS; NERVOUS SYSTEM DISEASES; PAIN; RANDOMIZED CONTROLLED TRIALS; UNITED STATES;

EID: 27844535799     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Guay DR. Adjunctive agents in the management of chronic pain. Pharmacotherapy. 2001;21:1070-1081.
2. Savage R. Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly? Drugs Aging. 2005;22:185-200.
3. D'Ambrosia RD. Epidemiology of osteoarthritis. Orthopedics. 2005;28(2 Suppl):S201-S205.
4. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646-656.
5. Grabois M. Management of chronic low back pain. Am J Phys Med Rehabil 2005;84(3 Suppl):S29-S41.
6. Benoist M. Natural history of the aging spine. Eur Spine J. 2003;12 Suppl 2:S86-S89.
7. Atkinson JH. Chronic back pain: searching for causes and cures. J Rheumatol. 2004;31:2323-2325.
8. Manek NJ, MacGregor AJ. Epidemiology of back disorders: prevalence, risk factors, and prognosis. Curr Opin Rheumatol. 2005;17:134-140.
9. Buckwalter JA, Mankin HJ, Grodzinsky AJ. Articular cartilage and osteoarthritis. Instr Course Lect. 2005;54:465-480.
10. van Tulder M, Koes B, Bombardier C. Low back pain. Best Pract Res Clin Rheumatol. 2002;16:761-775.
11. Ventafridda V, Saita L, Ripamonti C, De Conno F. WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React. 1985;7:93-96.
12. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59:850-856.
13. Schneider JP. Chronic pain management in older adults: with coxibs under fire, what now? Geriatrics. 2005;60:26-28, 30-21.
14. D'Alessandro R. Tizanidine for chronic cluster headache. Arch Neurol. 1996;53:1093.
15. Berry H, Hutchinson DR. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J Int Med Res. 1988;16:75-82.
16. Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache. 2002;42:470-482.
17. Nakashima K, Tumura R, Wang Y, Shimoda M, Salzuma K, Talzahashi K. Effects of tizanidine administration on exteroceptive suppression of the temporalis muscle in patients with chronic tension-type headache. Headache. 1994;34:455-457.
18. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician. 2005;71:483-490.
19. Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology. 2001;57:1583-1588.
20. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2004;110:697-706.
21. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116:109-118.
22. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50(6 Suppl):S205-S224.
23. Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther. 2004;26:1355-1367.
24. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004;28:140-175.
25. Casale R, Glynn CJ, Buonocore M. Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo. Arch Phys Med Rehabil. 1995;76:660-665.
26. Battla H, Silverblatt CW. Clinical trial of amitriptyline and fluphenazine in diabetic peripheral neuropathy. South Med J. 1981;74:417-418.
27. Mitas JA 2nd, Mosley CA Jr, Drager AM. Diabetic neuropathic pain: control by amitriptyline and fluphenazine in renal insufficiency. South Med J. 1983;76:462-463, 467.
28. Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain. 2000;16:188-192.
29. Mayer DJ, Mao J, Holt J, Price DD. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A. 1999;96:7731-7736.
30. Carlsson KC, Hoem NO, Moberg ER, Mathisen LC. Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol Scand. 2004;48:328-336.
31. Inturrisi CE. Pharmacology of methadone and its isomers. Minerva Anestesiol. 2005;71:435-437.
32. Pud D, Eisenberg E, Spitzer A, Adler R, Fried G, Yarnitsky D. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain. 1998;75:349-354.
33. Lipton SA. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr Alzheimer Res. 2005;2:155-165.
34. Ashina S, Bendtsen L, Jensen R. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain. 2004;108:108-114.
35. Bombardier C, Laine L, Reicin A, et al; VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520-1528.
36. Waxman HA. The lessons of Vioxx-drug safety and sales. N Engl J Med. 2005;352:2576-2578.
37. Truitt KE, Sperling RS, Ettinger WH Jr, et al; Phase III Rofecoxib Geriatric Study Group. A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis. Aging (Milano). 2001;13:112-121.
38. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet. 1988;1:9-11.
39. Mason L, Moore RA, Deny S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004;328:991.
40. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000;49:574-579.
41. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004;164:2017-2023.
42. Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ. 2004;171:333-338.
43. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31:2002-2012.
44. Di Rienzo Businco L, Di Rienzo Businco A, D'Emilia M, Lauriello M, Coen Tirelli G. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms. Acta Otorhinolaryngol Ital. 2004;24:279-283.
45. Galer BS, Gammaitoni AR, Oleka N, Jensen MP, Argoff CE. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin. 2004;20 Suppl 2:5-12.
46. Gammaitoni AR, Galer BS, Onawola R, Jensen MP, Argoff CE. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin. 2004;20 Suppl 2:S13-S19.
47. Galer BS, Sheldon E, Patel N, Codding C, Burch F, Gammaitoni AR. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Curr Med Res Opin. 2004;20:1455-1458.
48. Blumstein H, Gorevic PD. Rheumatologic illnesses: treatment strategies for older adults. Geriatrics. 2005;60:28-35.
49. Dodick D, Blumenfeld A, Silberstein SD. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Clin Dermatol. 2004;22:76-81.
50. Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology. 2001;56:1290-1293.
51. Breivik H. Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain. 2005;9:127-130.
52. Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage. 2003;26:1026-1048.
53. Peloso PM, Bellamy N, Bensen W, et al. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol. 2000;27:764-771.
54. Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z, Parke AC. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain. 1995;62:169-178.
55. Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853-860.
56. Hale ME, Fleischmann R, Salzman R, et al. Efficacy and safety of controlled-release versus immediate-release oxycodone: randomized, double-blind evaluation in patients with chronic back pain. Clin J Pain. 1999;15:179-183.
57. Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347:143-147.
58. Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain. 2005;6:21-28.
59. Lehmann LJ, DeSio JM, Radvany T, Bikhazi GB. Transdermal fentanyl in postoperative pain. Reg Anesth. 1997;22:24-28.
60. McCarberg BH. Introduction. Pain and the elderly. Clin J Pain. 2004;20:205-206.
61. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988;14:9-17.
62. Hanlon JT, Ruby CM, Guay D, Artz M. Geriatrics. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy. 5th ed. Stamford, Conn: Appleton & Lange; 1999.
63. Turk DC. Are pain syndromes acute or chronic diseases? Clin J Pain. 2000;16:279-280.
64. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524-1534.
65. Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H: Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;63:959-965.
66. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. 1996;65:39-44.
67. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999;80:553-538.
68. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003;106:151-158.
69. King RB. Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neurol. 1993;50:1046-1053.
70. Robbins W. Clinical applications of capsaicinoids. Clin J Pain. 2000;16:S86-S89.
71. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 1988;38:1427-1432.
72. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157:1531-1536.
73. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998;51:1166-1171.
74. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 1990;47:305-312.
75. McCue RE. Using tricyclic antidepressants in the elderly. Clin Geriatr Med. 1992;8:323-334.
76. Mackin GA. Medical and pharmacologic management of upper extremity neuropathic pain syndromes. J Hand Ther. 1997;10:96-109.
77. Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990;42:135-144.
78. Wernicke J, Rosen AS, Lu Y, et al. The safety of duloxetine in the long-term treatment of diabetic neuropathic pain. J Pain. 2004;5:48.
79. Rice AS, Maton S; Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 2001;94:215-224.
80. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110:628-638.
81. Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain. 1999;83:85-90.
82. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005;2:e164. Epub.
83. Dellemijn PL, Vanneste JA. Randomised double-blind active-placebo- controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet. 1997;349:753-758.
84. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 1991;41:1024-1028.
85. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837-1841.
86. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain. 2001;90:47-55.